An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
This workshop explores the application of currently available digital health technology to the management of type 2 diabetes, including continuous glucose monitoring, activity and sleep monitoring, mHealth applications and telemedicine. Both benefits and current barriers to the application of digital health to diabetes management will be fully explored.
Meeting Objectives
Provide an overview of current digital health technology (DHT) available for optimizing the management of type 2 diabetes mellitus
Review continuous glucose monitoring (CGM)-derived digital biomarkers and the use of CGM as a behavior modification tool
Examine current mHealth applications for monitoring activity, sleep, weight, ecological momentary assessment, and dietary intake
Explore patient and provider perspectives on the use of DHT to manage diabetes
Discuss the use of telemedicine to provide synchronous and asynchronous care in patients with diabetes
To understand current federal agency initiatives and perspectives on the application of DHT to diabetes management
Explore digital inclusivity as a pre-requisite to the widespread application of DHT to type 2 diabetes management
Examine the sustainability of DHT applications in type 2 diabetes management
Registration Deadline
September 4, 2024
Agenda
Thursday, September 5, 2024
8:30 a.m. – 8:35 a.m.
Welcome and Opening Remarks
Dr. William Cefalu, Director, Division of Diabetes, Endocrinology, and Metabolic Diseases,
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)
Dr. Griffin P. Rodgers, Director, NIDDK, NIH
8:35 a.m. – 8:45 a.m.
Overview of Workshop
Dr. Henry Burch, NIDDK, NIH
Introduction of Chairs
Dr. David Kerr, Sutter Health
Dr. Anne Peters, University of Southern California
Dr. Michael Snyder, Stanford University School of Medicine
Session I: Setting the Stage: Digital Health Technology -Type 2 Diabetes (DHT-T2D) 2024: Plenary Talk
Moderator(s): Dr. Henry Burch, NIDDK, NIH
8:45 a.m. – 9:15 a.m.
The Big Picture: Digital Health Technology for Chronic Disease Management
Dr. Geoffrey Ginsburg, All of Us Research Program, NIH
9:15 a.m. – 9:25 a.m.
Digital Stretch Break
Session II: Continuous Glucose Monitoring in Persons with T2 Diabetes
Moderator(s): Dr. Richard Bergenstal, International Diabetes Center Dr. Guillermo Arreaza-Rubin, NIDDK, NIH
9:25 a.m. – 9:45 a.m.
Overview of Continuous Glucose Monitor (CGM) Devices and Methodology
Dr. Anders Carlson, International Diabetes Center
9:45 a.m. – 10:05 a.m.
Update on CGM Studies in T2D
Dr. Grazia Aleppo, Northwestern University
10:05 a.m. – 10:25 a.m.
New Glycemia Indices – Going Beyond A1c
Dr. Richard Bergenstal, International Diabetes Center
10:25 a.m. – 10:45 a.m.
Integration of CGM into Clinic Workflow
Dr. David Maahs, Stanford University
10:45 a.m. – 11:15 a.m.
Moderated Discussion
11:15 a.m. – 11:30 a.m.
Break
Session III: Wearable Devices and Mobile Health Applications
Moderator(s): Dr. Michael Snyder, Stanford University School of Medicine Dr. Henry Burch, NIDDK, NIH
11:30 a.m. – 11:50 a.m.
Activity Monitoring in T2D – Is it Effective?
Dr. Michael Riddell, University of York
11:50 a.m. – 12:10 p.m.
Mobile Applications for Assessing Dietary Intake
Dr. Anne-Julie Tessier, Harvard University
12:10 p.m. – 12:30 p.m.
Digital Sleep Tracking in Diabetes
Dr. Michael Snyder, Stanford University
12:30 p.m. – 12:50 p.m.
Wearable-Derived Digital Biomarkers of Prediabetes and Diabetes
Dr. Jessilyn Dunn, Duke University
12:50 p.m. – 1:50 p.m.
Working Lunch and Moderated Discussion
1:50 p.m. – 2:00 p.m.
Stretch Break
Session IV: Bidirectional Communication – Patient and Provider
Moderator(s): Dr. Anne Peters, University of Southern California Dr. David Kerr, Sutter Health Dr. Shavon Artis Dickerson, NIDDK, NIH
2:00 p.m. – 2:20 p.m.
Use of Remote CGM Monitoring for People with Type 2 Diabetes Living in Under-Resourced Settings
Dr. Anne Peters, University of Southern California
2:20 p.m. – 2:40 p.m.
Technology Access as a Social Determinant of Health
Dr. David Kerr, Sutter Health
2:40 p.m. – 3:00 p.m.
Digital Navigation: Assessing and Addressing Digital Literacy Barriers
Dr. Lyndsay Nelson, Vanderbilt University
3:00 p.m. – 3:20 p.m.
Primary Care Perspective on Patient Engagement with DHT
Dr. Thomas Grace, Blanchard Valley Health System
3:20 p.m. – 4:00 p.m.
Moderated Discussion
4:00 p.m.
Meeting Adjournment
Friday, September 6, 2024
Session V: Sustaining Patient Engagement in Digital Health Interventions
Moderator(s): Dr. Maureen Monaghan-Center, NIDDK, NIH Dr. Theresa Woo, NIDDK, NIH
8:30 a.m. – 8:50 a.m.
Patient Perspectives on DHT Engagement – Taped Interviews – Two Patients from Divergent Clinical Settings
Dr. Anne Peters, University of Southern California
8:50 a.m. – 9:10 a.m.
Digitally Delivered Behavioral Economics in Diabetes Management
Dr. Jeffrey Kullgren, University of Michigan
9:10 a.m. – 9:30 a.m.
Peer Networking in Digital Diabetes Management
Dr. Michelle Litchman, University of Utah
9:30 a.m. – 9:50 a.m.
Digital Gaming Applications for Health Management
Dr. Veronica Brady, University of Texas
9:50 a.m. – 10:20 a.m.
Moderated Discussion
10:20 a.m. – 10:35 a.m.
Break
Session VI: Federal Agency Perspective on Implementation of DHT for T2D
Moderator(s): Moderator(s): Dr. William Cefalu, Chair, DEM and Chair, DMICC, NIDDK, NIH
10:35 a.m. – 10:55 a.m.
FDA Digital Health Center of Excellence Overview
Dr. Matthew Diamond, Chief Medical Officer, Digital Health Center of Excellence
10:55 a.m. – 11:15 a.m.
Veterans Affairs Initiatives on DHT in T2D
Dr. Meredith Josephs, Director, Connected Health, Veterans Administration
11:15 a.m. – 11:35 a.m.
Centers for Disease Control and Prevention’s (CDC) Global Digital Health Strategy
Dr. Christopher Holliday, Director, Division of Diabetes Translation
11:35 a.m. – 12:05 p.m.
Panel Discussion (FDA, VA, CDC)
12:05 p.m. – 12:35 p.m.
Lunch Break (Box Lunches)
Session VII: Multimodality Approaches to Diabetes Management, Data Aggregation, and EHR Integration
Moderator(s): Dr. David Klonoff, University of California, San Francisco Dr. Xujing Wang, NIDDK, NIH
12:35 p.m. – 12:55 p.m.
Welldoc/BlueStar
Dr. Anand Iyer, Chief Artificial Intelligence Officer
12:55 p.m. – 1:15 p.m.
Virta Health
Dr. Rebecca Adams, Verily Health Director of Research
1:15 p.m. – 1:35 p.m.
Verily/Onduo
Dr. Eric Huang, Verily Health
1:35 p.m. – 1:55 p.m.
Data Aggregation and EHR Integration
Dr. Juan Espinoza, Lurie Children’s Hospital Center
1:55 p.m. – 2:25 p.m.
Moderated Discussion
2:25 p.m. – 2:40 p.m.
Break
Session VIII: Summary of Research Gaps Identified During Workshop and Closing Remarks
Moderator: Moderator: Dr. Henry Burch, NIDDK, NIH
2:40 p.m. – 3:00 p.m.
Summary of Identified Research Gaps
Panel of Section Moderators
3:00 p.m. – 3:45 p.m.
Closing Remarks
Dr. David Kerr, Sutter Health
Dr. Anne Peters, University of Southern California
Dr. Michael Snyder, Stanford University
Dr. Henry Burch, NIDDK, NIH
Dr. William Cefalu, NIDDK, NIH
3:45 p.m.
Meeting Adjournment
Event Logistics
Registration
Registration Closed
Registration ended
Location
NIH Campus 31 Center Drive Building 31, 6C, Rooms A&B Bethesda,MD20894
Webinar
This is a hybrid workshop. Virtual participation is available. For those attending via webinar, the link will be distributed via email prior to the date of the event.
Contacts
Program Contact
Henry Burch, M.D.
Email: henry.burch@nih.gov
NIDDK
T: 301-827-0827
Meeting Logistics
Mark Dennis
Email: mdennis@scgcorp.com
The Scientific Consulting Group, Inc.
T: 301-670-4990
